Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

Hospital President Criticizing Drug Rollback Prices Sat on Moderna’s Board

coronavirus 

One of the loudest protesters against rolling back drug prices was Dr. Elizabeth Nabel, president of Brigham and Women’s Hospital, who wrote an op-ed for The Detroit News in February 2020, claiming rolling back prices would cripple drug company innovation.

The only problem was that Nabel failed to disclose that, at the time, she was sitting on the board of Moderna, a drug company ramping up production of remdesivir, a COVID-19 drug that the company recently said will cost $3,120 a week for a five-day course, per patient.

July 30, 2020, Moderna announced that Nabel had resigned from the board. Her husband, Dr. Gary Nabel, continues his position as chief scientific officer for Sanofi.

SOURCES:

Stat News August 7, 2020

Boston Globe August 6, 2020

The Detroit News February 13, 2020

WCVB5 August 5, 2020

Business Wire July 30, 2020